Advancement in Novel Drug Delivery System: Niosomes
Niosomes represent a promising drug delivery module. Noisome same as to liposome and Noisome represent alternative vesicular drug delivery systems with respect to liposomes, due to the noisome ability to encapsulate the different type of drugs within their multi environmental structure. Niosomes are thoughts to be a better system for drug delivery as compared to liposomes due to various factors like cost, stability etc. They are many types of drug deliveries that can be possible using niosomes like targeting, ophthalmic, topical, parenteral, etc. In recent research, comprehensive research carried over noisome as a drug carrier. Various drugs are enlisted and tried in noisome surfactant vesicles. Niosomes proved to better drug carrier system and has the potential to reduce the side effects of drugs and increased therapeutic effectiveness in various diseases. Noisome used more than fifty drugs are tried in niosomal formulations by the intravenous route, per oral administration, trans-dermal route of administration, and inhalation preparation, ocular nasal route of administration. Treatment of infectious diseases and immunization has undergone a revolutionary work in recent years. The large numbers of disease-specific biological have been developed, and also emphasis has been made to effectively deliver these biological. Niosomes shows an emerging class of novel vesicular systems. Niosomes are self-assembled vesicles composed primarily of synthetic surfactant and cholesterol. Comprehensive research carried over noisome as a drug carrier. Various drugs are enlisted and tried in noisome surfactant vesicles. This article presents an overview of the techniques of preparation of noisome, types of noisome, characterization and their applications.
Keywords-Niosomes; Method of preparation; Evaluation study; Application of Niosomes
2. Makeshwar K, Wasankar S. Niosomes: a novel drug delivery system. Asian J. Pharm. Res. 2013; 3: 16-20.
3. Punithavalli G, Vignesh M. Formulation of Niosomal Suspension with enhanced oral bioavailability of Diclofenac sodium. Journal of Global Trends in Pharmaceutical Sciences. 2012; 3: 656-671.
4. Katare R, Gupta P, Mahor S, Rawat A, Khatri K, Katare Y, Panda A, Vyas S. Development of polysaccharide-capped niosomes for oral immunization of tetanus toxoid. Journal Drug Del. Sci. Tech. 2006; 16: 167-172.
5. Shahiwala A, Misra A. Studies in topical application of niosomally entrapped Nimesulide. Journal of Pharm. Pharmaceut. Sci. 2002; 5: 220-225.
6. Bagheri A, Chu B, Yaakob H. Niosomal Drug Delivery Systems: Formulation, Preparation and Applications. World Applied Sciences Journal. 2014; 32: 1671-1685.
7. Sudheer P, Kaushik K. Review on Niosomes- A Novel Approach for Drug Targeting, Journal of Pharmaceutical Research. 2015; 1-14.
8. Sunilkumar M. Niosomes As novel drug delivery system. International Research Journal of Pharmaceutical and Applied Science. 2015; 5: 1-7.
9. Sankhyan A, Pawar P. Recent Trends in Niosome as Vesicular Drug Delivery System. Journal of Applied Pharmaceutical Science. 2012; 2: 20-32.
10. Gurjar P. Niosome: A Promising Pharmaceutical Drug Delivery. Int. J. Pharm Anal. 2014; 2: 425-431
11. Madhav N, Saini A. Niosomes: A novel drug delivery system. International journal of research in pharmacy and chemistry. 2011; 1: 498-511.
12. Gandhi A, Sen S, Paul A. Current Trends in Niosomes As vesicular drug delivery system. Asian Journal of Pharmacy and Life Science. 2012; 2: 339- 353.
13. Chauhan S, Laurence MJ. The preparation of polyoxyethylene containing non-ionic surfactant vesicles. J. Pharm. Pharmacol. 1986; 4: 6.
14. Verma A. A vital role of niosomes on Controlled and Novel Drug delivery. Indian Journal of Novel Drug Delivery. 2011; 3: 238-246.
15. Arul J, Shanmuganathan S, Nagalakshmi. An Overview on Niosome as Carrier in Dermal Drug Delivery. Journal of pharmaceutical sciences and research. 2015; 7: 923-927.
16. Moghassemi S, Hadjizadeh A. Nano-niosomes as Nanoscale Drug Delivery Systems: An illustrated review. Journal of Controlled Release. 2014; 2: 22-36.
17. Tangriet P. Niosomes: Formulation and Evaluation. International Journal of Biopharmaceutics. 2011; 2: 47-53.
18. Arul J. An Overview on Niosome as Carrier in Dermal Drug Delivery. J. Pharm. Sci. & Research. 2015; 7: 923-929.
19. Vyas S, Khar R. Targeted and Controlled Drug Delivery, Novel Carrier System. CBS publication. 2007; 1: 249-279.
20. Goswami S, Pathak D. Niosomes- A review of current status and application, World Journal of Pharmacy and Pharmaceutical Sciences. 2017; 6: 594-615.
21. Gayatri D, Venkatesh P, Udupa N. Niosomal sumatriptan succinate for nasal administration. Int. J. Pharm. Sci. 2000; 62: 479-481.
22. Hu C, Rhodes D. Proniosomes: A novel drug carrier preparation. Int J. Pharm. 1999; 185: 23-35.
23. Silver BL. The physical chemistry of membranes. New York: Alan/Unwin and Solomon Press. 1985; 209-230.
24. Khandare J, Madhavi G, Tamhankar B. Niosomes novel drug delivery system. The East Pharmacist. 1994; 37: 61-64.
25. Maver L, Bally M, Hope M, Cullis P. Biochem. Biophys. Acta. 1985; 816: 294-302.
26. Blazek-Walsh A, Rhodes D. SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes. Pharm. Res. 2001; 18: 656-661.
27. Baillie A, Florence A, Hume L, Muirhead G, Rogerson A. The preparation and properties of niosomes non-ionic surfactant vesicles. J. Pharm. Pharmacol. 1985; 37: 863-868.
28. Debnath A, Kumar A. Structural and Functional significance of Niosome and Proniosomes in Drug Delivery System. International Journal of Pharmacy and Engineering. 2015; 3: 621-637.
29. Jindal K. Niosomes as a Potentials Carrier System: A Review. IJPCBS. 2015; 5: 947-959.
30. Kaur H, Dhiman S, Arora S. Niosomes: A novel drug delivery system. Int. J. Pharm. Sci. Rev. Res. 2012; 15: 113-120.
31. Navya M. Niosomes As novel vesicular drug delivery system- A review. Asian Journal of Research in Biological and Pharmaceutical Sciences. 2014; 2: 62- 68.
32. Verma N. Niosomes and Its Application -A Review. IJRPLS. 2014; 2: 182- 184.
33. Sharma S. Span-60 Niosomal Oral Suspension of Fluconazole: Formulation and in vitro evaluation. Asian journal of pharmaceutical research and health care. 2009; 1: 142-156.
34. Suzuki K, Sokan K. The Application of Liposomes to Cosmetics. Cosmetic and Toiletries. 1990; 105: 65 78.
35. Tabbakhian M, Tavakoli N, Jaafari M, Daneshamouz S. Enhancement of follicular delivery of finasteride by liposomes and niosomes. Int. J. Pharm. 2006; 323: 1-10.
36. Namdeo A, Jain N. Niosomes as drug carriers. Indian Journal of Pharm. Sci. 1996; 58: 41-46.
37. Rai A. Niosomes: An approach to current drug delivery-A Review. International Journal of Advances in Pharmaceutics. 2017; 06: 41-48.
38. Srivastav A, Das P. To Study the Formulation of Niosome of Ofloxacin and Its Evaluation for Efficacy of Anti-Microbial. International Journal of Innovative Research in Science, Engineering and Technology. 2014; 3: 17958-17965.
39. Mishra N, Srivastava V, Kaushik A, Chauhan V, Srivastava G. Formulation and in vitro- evaluation of Niosomes of Aceclofenac. JSIR. 2014; 3: 337-341.
40. Bayindir Z, Yuksel N. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. Journal of Pharmaceutical Sciences. 2010; 99: 2049-2060.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open Access).